5th Cir. Reverses Summary Judgment Award to Drug Makers in Abilify Action



DOCUMENTS
  • Opinion


NEW ORLEANS — A federal appeals panel has reversed an award of summary judgment to the makers of Abilify, finding the deposition testimony created a question of fact as to whether the plaintiff was aware of a connection between the drug and his involuntary mouth movements before the expiration of the one-year prescriptive period.

In a March 13 opinion, the 5th Circuit U.S. Court of Appeals panel found the testimony revealed a possibility that the plaintiff did not know Abilify could cause tardive dyskinesia — a neurological disorder —and that his doctors did not warn him as such.

Raymond Crochet …

FIRM NAMES
  • Baker Donelson Bearman Caldwell & Berkowitz
  • Irwin Fritchie Urquhart & Moore
  • Taggart Morton
  • Winston & Strawn





UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: Midwest Asbestos Litigation

December 02, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS